Freireich EJ - Search Results

1

Hematologic response of four patients with smoldering acute myelogenous leukemia to partially pure gamma interferon.

Beran M, Andersson B, Kantarjian H, Keating M, Rios A, McCredie KB, Freireich EJ, Gutterman J. Beran M, et al. Among authors: freireich ej. Leukemia. 1987 Jan;1(1):52-7. Leukemia. 1987. PMID: 2444829

2

Late relapses in acute myeloid leukemia: analysis of characteristics and outcome.

Verma D, Kantarjian H, Faderl S, O'Brien S, Pierce S, Vu K, Freireich E, Keating M, Cortes J, Ravandi F. Verma D, et al. Leuk Lymphoma. 2010 May;51(5):778-82. doi: 10.3109/10428191003661852. Leuk Lymphoma. 2010. PMID: 20196624 Free PMC article.

3

Suppression of c-myc and c-myb expression in myeloid cell lines treated with recombinant tumor necrosis factor-alpha.

Schachner J, Blick M, Freireich E, Gutterman J, Beran M. Schachner J, et al. Leukemia. 1988 Nov;2(11):749-53. Leukemia. 1988. PMID: 3054350

4

Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to work.

de Lima M, Strom SS, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich E, Estey E. de Lima M, et al. Blood. 1997 Dec 15;90(12):4719-24. Blood. 1997. PMID: 9389687 Free article.

5

Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.

Verstovsek S, Kantarjian H, Estey E, Aguayo A, Giles FJ, Manshouri T, Koller C, Estrov Z, Freireich E, Keating M, Albitar M. Verstovsek S, et al. Leukemia. 2001 Aug;15(8):1165-70. doi: 10.1038/sj.leu.2402182. Leukemia. 2001. PMID: 11480557

6

Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.

Keating MJ, Estey E, Kantarjian H, Plunkett W, O'Brien S, Koller C, Beran M, Freireich EJ. Keating MJ, et al. Among authors: freireich ej. Leukemia. 1992;6 Suppl 2:78-80. Leukemia. 1992. PMID: 1578950 Review. No abstract available.

7

Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia.

Freireich EJ, Cork A, Stass SA, McCredie KB, Keating MJ, Estey EH, Kantarjian HM, Trujillo JM. Freireich EJ, et al. Leukemia. 1992 Jun;6(6):500-6. Leukemia. 1992. PMID: 1602788

8

Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

Kantarjian HM, Talpaz M, Keating MJ, Estey EH, O'Brien S, Beran M, McCredie KB, Gutterman J, Freireich EJ. Kantarjian HM, et al. Among authors: freireich ej. Cancer. 1991 Sep 15;68(6):1201-7. doi: 10.1002/1097-0142(19910915)68:6<1201::aid-cncr2820680604>3.0.co;2-1. Cancer. 1991. PMID: 1873771

9

Highly oncolytic adherent lymphocytes: therapeutic relevance for leukemia.

Lotzová E, Savary CA, Totpal K, Schachner J, Lichtiger B, McCredie KB, Freireich EJ. Lotzová E, et al. Among authors: freireich ej. Leuk Res. 1991;15(4):245-54. doi: 10.1016/0145-2126(91)90127-f. Leuk Res. 1991. PMID: 2030606

10

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor.

Estey EH, Dixon D, Kantarjian HM, Keating MJ, McCredie K, Bodey GP, Kurzrock R, Talpaz M, Freireich EJ, Deisseroth AB, et al. Estey EH, et al. Among authors: freireich ej. Blood. 1990 May 1;75(9):1766-9. Blood. 1990. PMID: 2184901 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

581 results

Search Page

Filters